Literature DB >> 7979584

Reconstitution of the alternative pathway of complement by plasma infusions given to a patient with an SLE-like syndrome associated with a hereditary C3 dysfunction.

B Nilsson1, U R Nilsson, A Karlsson-Parra, G Sjölin-Forsberg, R Hällgren.   

Abstract

OBJECTIVE: To reconstitute a dysfunctional form of complement factor C3 in a patient with a systemic lupus erythematosus (SLE)-like syndrome.
METHODS: The propositus was treated with plasma infusions during five sessions over a period of eight months.
RESULTS: The alternative pathway was reconstituted to normal levels for approximately two to three days after each infusion. C3 fragments were incorporated into previously detected deposits of IgG and IgM at the dermal-epidermal junction and the immune complex levels gradually decreased during the whole treatment period.
CONCLUSION: The reconstitution appears to result in the solubilisation of tissue immune complexes and a subsequent transportation to the fixed macrophage system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979584      PMCID: PMC1005438          DOI: 10.1136/ard.53.10.691

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

Review 1.  Complement deficiency and disease.

Authors:  B P Morgan; M J Walport
Journal:  Immunol Today       Date:  1991-09

2.  Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis.

Authors:  U R Nilsson; B Nilsson; K E Storm; G Sjölin-Forsberg; R Hällgren
Journal:  Arthritis Rheum       Date:  1992-05

3.  Simplified assays of hemolytic activity of the classical and alternative complement pathways.

Authors:  U R Nilsson; B Nilsson
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

4.  Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis.

Authors:  B E Bourke; I K Moss; R N Maini
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

Review 5.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

6.  Defective Fc receptor-mediated clearance in patients with primary biliary cirrhosis.

Authors:  K N Ekdahl; L Lööf; A Nyberg; U R Nilsson; B Nilsson
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

7.  Generation of iC3 at the interface between blood and gas.

Authors:  K Nilsson Ekdahl; B Nilsson; M Pekna; U R Nilsson
Journal:  Scand J Immunol       Date:  1992-01       Impact factor: 3.487

8.  Successful plasma infusion treatment of a patient with C2 deficiency and systemic lupus erythematosus: clinical experience over forty-five months.

Authors:  K Steinsson; K Erlendsson; H Valdimarsson
Journal:  Arthritis Rheum       Date:  1989-07
  8 in total
  3 in total

1.  Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis.

Authors:  B J Harrison; C E Hutchinson; J Adams; I N Bruce; A L Herrick
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activity.

Authors:  Georgia Sfyroera; Daniel Ricklin; Edimara S Reis; Hui Chen; Emilia L Wu; Yiannis N Kaznessis; Kristina N Ekdahl; Bo Nilsson; John D Lambris
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

3.  Progress and Trends in Complement Therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.